GoodRX sets lender call for $155 million incremental first-lien loan

By Paul A. Harris

Portland, Ore., Oct. 22 – GoodRX plans to kick off a $155 million fungible incremental first-lien term loan on a lender call scheduled to get underway at 11 a.m. ET on Wednesday, according to a market source.

Goldman Sachs is the left bookrunner. Barclays, BofA Securities, Inc., Credit Suisse, KKR, Citizens and SunTrust Robinson Humphrey are the joint bookrunners.

The Santa Monica, Calif.-based company plans to use the proceeds, along with cash on hand, to refinance its existing second-lien term loan.

GoodRX operates a prescription drug price comparison and coupon platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.